Section 524B made medical device cybersecurity a legal requirement, not a guideline. Learn what the FDA expects from your pen test scope, evidence package, and postmarket vulnerability management process.

Semiconductor manufacturers face dual compliance obligations under CMMC 2.0 and the CHIPS Act and a standard pen test satisfies neither fully. Learn how to build a unified program that covers both frameworks.

Completing a pen test isn't enough for CMMC. Learn what C3PAO assessors actually look for in your evidence package and how to align your report, scope, POA&M, and remediation docs to specific practice statements.